Cutaneous T-Cell Lymphoma (CTCL) MDT Educational Meeting

Wednesday 29 June 2022, 4pm to 6pm – virtual

All patients referred into our supraregional unit are discussed in a multidisciplinary (MDT) meeting. This event is to share how the MDT functions with the opportunity to discuss cases from which we can all learn in an 'open MDT' meeting. General topics including areas of research and new developments will also be covered.

This event is aimed at multidisciplinary healthcare professionals, who care, and/or refer cutaneous T-cell lymphoma (CTCL) patients to The Christie within the North West region, including dermatologists, clinical oncologists, haematologists, histopathologists, clinical trainees, radiotherapy staff and nurses.

  • The Christie Supranetwork MDT: general updates on CTCL, current thinking , trends and clinical trials
  • MDT best practice
  • Interactive case presentations
  • Panel discussion

MDT Approach to diagnostic challenges and subsequent management of Cutaneous T Cell Lymphoma – Wednesday 29 June 2022






An introduction to the MDT members and their roles. An explanation of how the MDT is run at The Christie, illustrating the patient pathway through diagnosis and into management


Newly approved therapies in CTCL


Clinical trials available for patients at The Christie


Comfort Break


Case Presentations highlighting diagnostic challenges and management decisions


Questions for the panel


Close of meeting

Speakers to include: 

  • Prof Richard Cowan: Consultant in clinical oncology and lead of the Manchester Supra regional Cutaneous Lymphoma Service 
  • Dr Christina Hague: Consultant in clinical oncology 
  • Dr Nina Farquharson: Consultant in dermatology 
  • Simeon Mitton: Lymphoma clinical nurse specialist

This educational meeting is organised by The Christie School of Oncology and funded by Kyowa Kirin Ltd.

Sign up to our education events mailing list to be kept up to date with this and future events

Last updated: May 2023